Skip to content

In the BioHarmony Drug Report Database

Lomefloxacin

Maxaquin, Quinsair (lomefloxacin) is a small molecule pharmaceutical. Lomefloxacin was first approved as Maxaquin on 1992-02-21. It is used to treat bronchitis, escherichia coli infections, klebsiella infections, proteus infections, and pseudomonas infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections.
Trade Name Quinsair
Common Name Lomefloxacin
Indication bronchitis, cystic fibrosis, escherichia coli infections, klebsiella infections, proteus infections, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections
Drug Class Antibacterials (quinolone derivatives)
Lomefloxacin
Get full access now